Ads
-
Related paper
- Long-Term Outcome of Approved Pharmacotherapy for Diabetic Macular Edema: A Review of Randomized Controlled Trials in Fluocinolone Acetonide Implants, Dexamethasone Implants, Aflibercept and Ranibizumab
- Analyse the Efficacy and Safety of Intravitreal Injection of Biosimilar Ranibizumab on Central Macular Thickness and Visual Outcome in Patients of Macular Edema
- Comparison Between Intravitreous Fluocinolone Acetonide Implant, Ozurdex Implant, and Cyclosporine in Treatment of Noninfectious Uveitic Macular Edema
- Real-Life Clinical Effectiveness of Razumab® (World’s First Biosimilar Ranibizumab) in Wet AgeRelated Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion: A Retrospective Pooled Analysis
- Intravitreal Triamcinolone Acetonide in Diabetic Macular Edema
- Reduced Diameter Implants - A Long Term Follow-Up
- COMPARISON OF INTRAVITREAL BEVACIZUMAB (AVASTIN) WITH TRIAMCINOLONE FOR TREATMENT OF DIFFUSED DIABETIC MACULAR EDEMA: A PROSPECTIVE RANDOMIZED STUDY
- Subperiosteal Implants in Treatment of Total and Partial Edentulism - A Long Term Follow Up
- CLINICAL AND RADIOGRAPHIC ASSESSMENT OF BOND APATITE IN HORIZONTAL BONE AUGMENTATION AROUND DENTAL IMPLANTS: A RANDOMIZED CONTROLLED TRIAL
- Assessment of immediate clinical outcome and short term prognosis of single tooth dental implants – A case series